智能纳米纤维用于重塑瘤微环境和循环瘤化疗免疫疗法放大
Manxiu Huai1, Yingjie Wang2, Junhao Li3
1Department of Gastroenterology Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Journal of nanobiotechnology
|May 16, 2024
概括
这项研究开发了一种双响应的纳米微粒 (ENP919@5-FU) 同载化疗和一种IDO1抑制剂,以克服胰腺癌治疗的挑战. 纳米纤维重塑瘤微环境,增强化疗免疫疗法,以提高抗瘤功效.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 免疫治疗是一种免疫疗法.
背景情况:
- 胰腺管道腺癌 (PDAC) 由于药物溶解性,特异性和免疫抑制微环境不佳而带来挑战.
- 目前的治疗方法,如5-fluorouracil (5-FU) 有局限性,包括诱导一个免疫抑制 kynurenine-aryl碳化合物受体 (Kyn-AHR) 轴.
研究的目的:
- 开发一种新的纳米纤维系统 (ENP919@5-FU) 用于增强PDAC中的化疗免疫治疗.
- 为了克服5-FU和免疫抑制瘤微环境的局限性.
主要方法:
- 构建了一个双响应的纳米纤维,同时加载5-FU和IDO1抑制剂NLG919.
- 设计了纳米纤维对矩阵金属蛋白酶-2 (MMP-2) 和谷氨 (GSH) 的反应.
- 在PDAC模型中评估了单独和与抗PD-L1抗体结合的纳米纤维的疗效.
主要成果:
- 通过MMP-2响应,ENP919@5-FU纳米纤维有效地准瘤,并在响应GSH时释放药物.
- 纳米纤维重塑了免疫抑制瘤微环境,增强了化疗免疫疗法.
- 与抗PD-L1联合治疗显示出协同作用的抗瘤作用,特别是在转移性PDAC模型中.
结论:
- 通过放大化疗免疫疗法,5-FU纳米微粒为PDAC治疗提供了一个有希望的策略.
- 这种方法有效地重塑了瘤微环境,显示了PDAC精准医学的潜力.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518